C
VERA icon

Covestor’s Vera Therapeutics VERA Stock Holding History

Covestor’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
15
+11
+275% +$410 ﹤0.01% 2377
2026
Q1 		$0 Hold
4
– – ﹤0.01% 2808
2025
Q4 		$0 Hold
4
– – ﹤0.01% 2773
2025
Q3 		$0 Hold
4
– – ﹤0.01% 2812
2025
Q2 		$0 Hold
4
– – ﹤0.01% 2792
2025
Q1 		$0 Buy
4
+1
+33% +$32 ﹤0.01% 2764
2024
Q4 		$0 Buy
3
+1
+50% +$44 ﹤0.01% 2777
2024
Q3 		$0 Sell
2
-1
-33% -$38 ﹤0.01% 2812
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2796
2024
Q1 		$0 Buy
+3
New +$107 ﹤0.01% 2785

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Covestor's VERA Position: Q2 2026 in Review

Covestor increased its Vera Therapeutics (VERA) stake by 275% in Q2 2026, buying an estimated $410 and bringing the position to 15 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2377.

Covestor first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Covestor held 15 shares of Vera Therapeutics worth $1K as of Q2 2026.
  • Covestor bought 11 Vera Therapeutics shares in Q2 2026, an estimated $410.
  • Vera Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2377 holding.
  • Covestor first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.